Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
Conditions:   Glucagon-Like Peptide-1 Receptor;   Metformin;   Obesity, Abdominal;   Diabetes Mellitus, Type 2;   Abdominal Fat;   Non-Alcoholic Fatty Liver Disease;   Metabolism Disorder, Glucose;   Metabolism Disorder, Lipid Interventions:   Drug: Liraglutide;   Drug: Semaglutide;   Drug: Metformin Sponsor:   RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2023 Category: Research Source Type: clinical trials